Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TIALIS ESSENTIAL IT PLC Capital/Financing Update 2019

Feb 12, 2019

7969_rns_2019-02-12_74436605-3fd5-45e0-8bad-178c09338f39.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6933P

IDE Group Holdings PLC

12 February 2019

IDE Group Holdings Plc

("IDE" or the "Company")

Result of Open Offer to Subscribe for Loan Notes

Further to the announcements of 10 January 2019 and 24 January 2019, IDE, the mid-market network, cloud and IT Managed Services provider, is pleased to announce the result of the open offer to subscribe for up to £4.7 million loan notes (the "Second Tranche LNs"). Valid acceptances in respect of £1 million Second Tranche LNs have been received. Under the terms of the Underwriting Agreement, MXC will subscribe for the remaining £3.7 million Second Tranche LNs. The proceeds of the Second Tranche LNs will be used to repay IDE's remaining debt facilities with Natwest and to provide additional working capital for the Company.

Where undefined, all capitalised terms in this announcement will have the same meaning as defined in the announcement published on 10 January 2019.

IDE Group Holdings Plc

Andy Parker, Executive Chairman
Tel: +44 (0)344 874 1000
finnCap Limited

Nominated Adviser and Broker

Corporate finance: Jonny Franklin-Adams/ Scott Mathieson/ Hannah Boros

ECM: Tim Redfern/ Richard Chambers
Tel: +44 (0)20 7220 0500
MXC Capital Markets LLP

Financial Adviser

Charlotte Stranner
Tel: +44 (0)20 7965 8149

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCBIGDDGBBBGCB